Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.

The Silicon Review highlights Ralph Dangelmaier’s insights on how self-improving and self-correcting payment workflows help enterprises gain efficiency and competitive edge.

Experts calls for greater transparency, stronger data infrastructure and clearer regulatory frameworks in the use of ...

Farming is changing from manual, experience-led observation to data-driven decision-making powered by advanced sensing systems and artificial intelligence. A new research paper titled “Fast Forward ...

Researchers at the University of California, Santa Cruz have trained lab-grown clusters of mouse brain cells to balance a ...

Discover why top product managers focus on systems rather than individual features in this insightful conversation with Siddharth Arora about strategy, product thinking, and building scalable ...

Brain-computer interfaces (BCIs), once the realm of neuroscience labs and speculative fiction, are rapidly becoming central to national technology plans. Over the past year China's top-level policy ...

Greetings, and welcome to the HeartBeam Fourth Quarter 2025 Financial Results Conference Call. [Operator Instructions]. As a reminder, today's conference is being recorded. Before we begin the formal ...

A conversation with Sir Stephen Fry is a whirlwind of eclectic and esoteric references across a staggering diversity of knowledge that is stochastically connected in his polymathic mind to produce ...

Elon Musk urged tech companies to “proceed with caution” after reports surfaced that Amazon Web Services suffered two separate outages last year, both triggered by AI tools operating within its cloud ...

The Artificial Intelligence Governance Professional (AIGP) certification focuses on managing and overseeing AI systems responsibly, not just building them. This certification is important because AI ...

In recent days, Jefferies and other Wall Street firms initiated and reiterated positive coverage on Gilead Sciences, highlighting its strong HIV franchise, deep oncology pipeline, and an ...